Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Yan Pei

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Scientific Reports|October 23, 2025
Rationally designed, ACE2 mimetic binder to the SARS Cov-2 associated Spike protein for COVID-19 therapeutics and beyondMichael H Peters, Xin Yan Pei
Molecular Cancer Therapeutics|January 7, 2005
The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanismXin-Yan Pei, Yun Dai, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitorsXin-Yan Pei, Yun Dai, Steven Grant
Molecular and Cellular Biology|October 7, 2009
Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1Shuang Chen, Yun Dai, Xin-Yan Pei, et al.
Molecular Pharmacology|August 31, 2006
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Weiqun Li, Yun Dai, et al.
Blood|March 25, 2004
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Statistical Methods in Medical Research|March 7, 2015
Experimental design and statistical analysis for three-drug combination studiesHong-Bin Fang, Xuerong Chen, Xin-Yan Pei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Yun Dai, Mohamed Rahmani, et al.
Blood|February 1, 2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationYun Dai, Payal Khanna, Shuang Chen, et al.
Blood|December 3, 2003
Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cellsYun Dai, Xin-Yan Pei, Mohamed Rahmani, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Scientific Reports|October 23, 2025
Rationally designed, ACE2 mimetic binder to the SARS Cov-2 associated Spike protein for COVID-19 therapeutics and beyondMichael H Peters, Xin Yan Pei
Molecular Cancer Therapeutics|January 7, 2005
The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanismXin-Yan Pei, Yun Dai, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitorsXin-Yan Pei, Yun Dai, Steven Grant
Molecular and Cellular Biology|October 7, 2009
Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1Shuang Chen, Yun Dai, Xin-Yan Pei, et al.
Molecular Pharmacology|August 31, 2006
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Weiqun Li, Yun Dai, et al.
Blood|March 25, 2004
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Statistical Methods in Medical Research|March 7, 2015
Experimental design and statistical analysis for three-drug combination studiesHong-Bin Fang, Xuerong Chen, Xin-Yan Pei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Yun Dai, Mohamed Rahmani, et al.
Blood|February 1, 2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationYun Dai, Payal Khanna, Shuang Chen, et al.
Blood|December 3, 2003
Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cellsYun Dai, Xin-Yan Pei, Mohamed Rahmani, et al.
Pageof 3